Eilmeldung

Massive Warehouse Fire in Boyle Heights Prompts Shelter-in-Place Order Hollister Partners with Target for Home and Dorm Decor Launch Trump Signs Iran War Framework, Economic Woes Persist, Intelligence Nominee Delayed National Mall to Host 'Great American State Fair' for 250th Anniversary Trump's Approval Ratings Plummet Amid Economic Concerns, Poll Shows Airlines Likely to Keep Ticket Price Hikes Despite Falling Fuel Costs US Defense Secretary Hegseth Criticizes NATO Allies, Announces Force Review Obama Presidential Center to Open with Star-Studded Dedication Ceremony World Shares Mixed as US-Iran Sign Initial War End Deal Detainees Transferred from 'Alligator Alcatraz' Amid Hurricane Season Concerns Massive Warehouse Fire in Boyle Heights Prompts Shelter-in-Place Order Hollister Partners with Target for Home and Dorm Decor Launch Trump Signs Iran War Framework, Economic Woes Persist, Intelligence Nominee Delayed National Mall to Host 'Great American State Fair' for 250th Anniversary Trump's Approval Ratings Plummet Amid Economic Concerns, Poll Shows Airlines Likely to Keep Ticket Price Hikes Despite Falling Fuel Costs US Defense Secretary Hegseth Criticizes NATO Allies, Announces Force Review Obama Presidential Center to Open with Star-Studded Dedication Ceremony World Shares Mixed as US-Iran Sign Initial War End Deal Detainees Transferred from 'Alligator Alcatraz' Amid Hurricane Season Concerns

MW150

Stabil1 Meldungen1 QuellenZuletzt aktualisiert: 22.05.2026

Verwandte Themenalcohol withdrawal brain inflammation University of Kentucky neuroinflammation p38α MAPK dementia Alzheimer's disease Neflamapimod

Neueste Meldungen

Experimental Drug MW150 Shows Promise in Reducing Brain Inflammation During Alcohol Withdrawal

22.05.2026KI-Zusammenfassung

Experimental Drug MW150 Shows Promise in Reducing Brain Inflammation During Alcohol Withdrawal

Scientists from the University of Kentucky have found that the experimental drug MW150 can reduce brain inflammation associated with alcohol withdrawal. Originally developed for dementia and Alzheimer's, MW150 targets the p38α MAPK pathway, which is linked to neuroinflammation.

Лента.ру